Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$5.52 USD
+0.28 (5.34%)
Updated Jun 26, 2024 04:00 PM ET
After-Market: $5.53 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 42% (146 out of 250)Zacks Sector Rank
Bottom 44% (9 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.52 | 9.99 |
Current Quarter Estimate | -0.60 | -2.04 | 57.00 |
Year Ago Quarter Estimate | -0.70 | -0.59 | 52.54 |
Next Quarter Estimate | -0.56 | -2.00 | 61.00 |
Next Year Estimate | -1.67 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 5.98 | 13.60 | 15.67 |
Next Year | 24.09 | 14.80 | 9.31 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | 9.20 | 24.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | NA | 1.76 |
Price/Cash Flow (MRFY) | NA | 8.23 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -274.23% | -63.34% |
Return on Equity (TTM) | NA | -60.39% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.